CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract]
REVENUES	$ 114,493	$ 114,802
Cost of product revenue	33,743	53,705
Gross profit	80,750	61,097
OPERATING EXPENSES:
Research and development	2,597	826
Plasma center operating expenses	1,062	1,286
Amortization of intangible assets	55	25
Gain on sale of plasma centers	(7,980)	0
Selling, general and administrative	26,742	24,079
Total operating expenses	22,476	26,216
INCOME FROM OPERATIONS	58,274	34,881
OTHER INCOME (EXPENSE):
Interest and other income	1,093	608
Interest expense	(2,100)	(1,975)
Other expense	(140)	(64)
Other income (expense), net	(1,147)	(1,431)
INCOME BEFORE INCOME TAXES	57,127	33,450
Provision for income taxes	11,799	6,546
NET INCOME	$ 45,328	$ 26,904
BASIC EARNINGS PER COMMON SHARE (in Dollars per share)	$ 0.19	$ 0.11
DILUTED EARNINGS PER COMMON SHARE (in Dollars per share)	$ 0.19	$ 0.11
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:
Basic (in Shares)	236,072,751	237,775,476
Diluted (in Shares)	239,955,762	244,676,350